Quantitative Systematic Strategies LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Quantitative Systematic Strategies LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$280,000
-55.8%
28,820
-51.1%
0.10%0.0%
Q1 2021$633,000
-35.4%
58,938
-11.5%
0.10%
-29.5%
Q4 2020$980,000
+19.2%
66,616
+15.1%
0.14%
-2.8%
Q3 2020$822,000
+100.0%
57,860
+13.9%
0.14%
+76.5%
Q2 2020$411,000
+463.0%
50,783
+180.4%
0.08%
+35.0%
Q1 2020$73,00018,1090.06%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 701,138$4,067,0000.67%
Matrix Capital Management Company, LP 2,288,560$13,274,0000.33%
NEA Management Company, LLC 1,250,000$7,250,0000.31%
Stanley-Laman Group, Ltd. 139,403$809,0000.20%
Cormorant Asset Management, LP 500,000$2,900,0000.19%
Tekla Capital Management LLC 468,399$2,717,0000.10%
Wealth Alliance Advisory Group, LLC 21,800$126,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 175,339$1,007,0000.03%
Artal Group S.A. 150,000$870,0000.02%
Baker Brothers Advisors 505,262$2,931,0000.02%
View complete list of TRILLIUM THERAPEUTICS INC shareholders